Core Viewpoint - The company plans to invest in Dongzhi Medical Technology (Shanghai) Co., Ltd. by acquiring equity and subscribing to new registered capital, aiming to enhance its competitive position in the regenerative product sector [1] Group 1: Investment Details - The company will acquire equity held by Lishai Management and Yuan Zheng in Dongzhi Medical, increasing its stake from 37.9528% to 50.9014% after the investment [1] - The company will inject an additional capital of 20 million into Dongzhi Medical as part of this investment [1] Group 2: Strategic Implications - This transaction is intended to meet the company's future strategic development needs [1] - The investment in Dongzhi Medical's biological patch products is expected to strengthen the company's competitiveness in the research and production of regenerative induction series products [1]